Finance

Beta
Lists
225220:KOSDAQ
Genolution Inc
₩1,479.00
+2.57%
(+37.00) 1D
Jun 17, 11:00:01 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 225220...
Open
₩1,442
High
₩1,480
Low
₩1,442
Mkt. cap
28.38B
Avg. vol.
64.68K
Volume
7.15K
52-wk high
₩2,830
52-wk low
₩1,350
EPS
-₩497
Shares outstanding
19.19M
No. of employees
75
Open
₩1,442
High
₩1,480
Low
₩1,442
Mkt. cap
28.38B
Avg. vol.
64.68K
Volume
7.15K
52-wk high
₩2,830
52-wk low
₩1,350
EPS
-₩497
Shares outstanding
19.19M
No. of employees
75
News stories
From sources across the web
About Genolution Inc
CEO-
Employees75
Founded2006
Headquarters-
SectorHealth care
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.88B
2.07B
2.38B
2.49B
Cost of goods sold
1.25B
1.34B
1.95B
1.59B
Cost of revenue
1.25B
1.34B
1.95B
1.59B
Research and development expenses
57.19M
125.29M
137.67M
124.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.71B
2.45B
1.92B
1.86B
Operating expense
3.33B
3.17B
2.46B
2.27B
Total operating expenses
4.58B
4.51B
4.41B
3.87B
Operating income
-1.69B
-2.44B
-2.02B
-1.38B
Other non operating income
39.34M
40.51M
202.81M
56.66M
EBT including unusual items
-3.74B
-1.26B
-5.33B
440.03M
EBT excluding unusual items
-3.72B
-1.49B
-1.12B
25.22M
Income tax expense
-
-
3.90M
-
Effective tax rate
-
-
-0.07%
-
Other operating expenses
100.07M
81.12M
44.13M
45.06M
Net income
-3.53B
-918.06M
-5.12B
597.22M
Net profit margin
-122.56%
-44.37%
-214.48%
24.03%
Earnings per share
-
-
-
-
Interest and investment income
280.38M
276.37M
304.38M
257.24M
Interest expense
-219.91M
-221.70M
-215.87M
-194.20M
Net interest expenses
60.47M
54.67M
88.51M
63.04M
Depreciation and amortization charges
465.64M
460.66M
433.75M
231.51M
EBITDA
-1.09B
-1.85B
-1.47B
-1.13B
Gain or loss from assets sale
56.72M
-30.67M
-495.00K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more